Table 9 Functional performance (NYHA) at baseline and at the end of follow up in the included cohort studies (n = 18)
| Â | N | Baseline | End of follow up | ||||||
|---|---|---|---|---|---|---|---|---|---|
I | II | III | IV | I | II | III | IV | ||
Sadowski 2015 [12] | 20 | 4 | 10 | 6 | Same or improved: 84.2% | ||||
Bartus 2018 [20] | 133 | 28 | 61 | 42 | 2 | Same or improved: 95.1% | |||
Bartus 2019 [21] | 28 | 61 | 43 | 1 | Improved: 54.5% | ||||
Bartus 2021 [22] | 28 | 61 | 43 | 1 | Same: 36.3%; Improved: 54.9% | ||||
Puskas 2017 [24] | 689 | 166 | 342 | 168 | 13 | Same: 31.0%; Improved: 65.7% | |||
Johnston 2021 [25] | 164 | 344 | 168 | 13 | Improved: 63.0% | ||||
Beaver 2023 [26] | 93.4% | 6.6% | |||||||
El-Sayed Ahmad 2021 [18] | 100 | 61 | 39 | NA | |||||
El-Sayed Ahmad 2022 [23] | 154 | NA | 134 | 3 | |||||
Bernard 2023 [32] | 217 | 61 | 156 | NA | |||||
Chiariello 2023 [35] | 74 | 18 | 56 | 60 | 14 | ||||
Francica 2023 [40] | 122 | 47 | 35 | 30 | 10 | NA | |||
Fukunaga 2022 [29] | 29 | 24 | 5 | NA | |||||
Maeda 2023 [34] | 64 | 52 | 12 | NA | |||||
Meuris 2023 [28] | 421 | 21.9% | 51.0% | 25.7% | 1.4% | 82.0% | 14.5% | 3.3% | 0.3% |
Porto 2023 [41] | 487 | 260 | 227 | 425 | 17 | ||||
Shala 2022 [33] | 59 | NA | NA | ||||||
Useini 2021 [27] | 80 | 40 | 40 | NA | |||||